Thank you, our continued quarter, call. and Ray. profit our momentum for Novanta record its thanks a everybody, beating joining and delivered morning, revenue Good and both guidance.
delivered company reported growth. representing in $XXX.X growth X% million Our year-over-year revenue, revenue revenue XX% and organic year-over-year
was $XX.X EBITDA adjusted which versus up XX% Our last is million, year.
$X.XX Our XXXX. per from was in $X.XX, of up earnings adjusted third which share quarter was XX% the
million outstanding In flow performance $XX.X operating the third addition, to with delivered quarter. flow we in cash growing cash
it profit quarter really all, was perspective. a fantastic in a from flow revenue, all So and cash
positions remain surgery, observe position core We drivers. we continue our automation about trend we large macro of businesses sequencing, vision positioning and growth long-term and to well such about for We secular and trends back on material medicine the health robotics. quarter, in industry in applications Particularly, see applications slowdowns excited productivity. in of did the precision and applications feel markets a around metrology, dynamics. DNA precision X.X, advanced need variety and the with growth not our motion, processing our of photonics capabilities a in converging few In as and a good care robotic
higher. momentum eight businesses In to our across we mid-single fact, broad-based all of growing seven continued see regions, in the growth or company quarter, with the and digits
XX% in medical Novanta year-to-date, of both XX% advanced an book book-to-bill bookings overall the We roughly core X.XX, were continue broad-based quarter market to segments growth We representing of to a the XX% versus have performance, and solid and XXXX. revenue. total saw with of also China industrial order applications. growing third Sales up
more uncertain potential result the dispute of a demand US and as climate. to China alert trade secondary staying factors a we're However, of investment
pipeline innovation launch our share We to continue products heavily and new gains. market drive invest in to
addition, application opportunities, cross-selling customer to geographical continue and expansion engine, serve. In identifying and to new driving commercial areas invest our we in
seeing already the are strategic our fruits We of growth efforts on our priorities.
revenue grew year-over-year. product than XX% year-to-date New more
which last above XX% revenue in four from index, launched to new be continues the Our products, years, is of vitality sales.
wins by by previously, as than Our accelerated nearly last year-to-date and versus XX% design and, from revenue increased China year-to-date XX% our increased discussed more year.
All us X% to organic X% our in average. gives on annual of this ability confidence to of deliver growth
operations Finally, net execution productivity by delivering contributions to in the I'm proud the of of side, the team, solid inflation. our
categories seeing. a dispute. on are take me US the communicated to there comment the on Based of two moment trade and Let we China headwinds date, are tariffs to
The product by our supply and from chain. of United first States tariffs China imported purchased are imposed as part
cases, second that norm. by imported situation and there assuming tariffs remains we fluid becomes products. new on imposed are both In very a one purchased the plan China The on US
significant and in properly we mitigate these customers to But effort our part our the impacts. time, As actions from articulated majority the of are a permanently we vendors and confident to past, on ultimately the corporation address. and take
and remainder look we the to year from the the As already of our our guidance sales impact the XXXX, our profit in imposed. tariffs for factors full at
As mitigate to about the impact many We XXXX before we and expect effects timing already are look seeing underway profit half the have the the some up progress completely $X out methods can to first do headwinds. that million actively with made. XXXX, we mitigation we we feel good of
to not expecting multitude can challenge. a we're you tools disposal a our of as material So feel impact address and have this at see, we
and year the details quarter strong on year the XXXX the confidence hear year us quarter will third Robert, You for and from outlook the results gave the but outlook finishing the more well. in full
our segments. turn Now, let operating me to
us and XX% XX% segment to for bookings year-over-year growth. fantastic growth be a year-over-year engine Precision with revenue Motion continued growth Our
our vehicles precision multiple automation, precise position structural in dynamic motion We as continue like markets. growth in metrology, functionality robotic to with control dynamics, surgery autonomous and robotics, such and markets
many with is Zettlex of with technology the motion products the well, and discovered date, the into really sales team acquisition cross-selling channels and integration. of performing of through Zettlex opportunities progress extremely the and we high-growth our pleased To control and quality Our our are we have applications. the business,
XX% new grew last our teams. In revenue more This and the execution to as by moved as Furthermore, we team new engineering of attractive grew innovations and market commercial proud our robotics I'm expanded the the mechatronic position new Precision we our are center beat year versus than revenue motors miss to a us as facility talent new more product needs we square better the customers. XX,XXX quarter, Motion an our more a a expanding didn't platforms. around and we're deliveries XX% than California. base established medical bringing to gives China address Rocklin, segment, Within of customers' our in to customers. year-to-date, they attract solutions operations to foot and now on of of the into component
Finally, to our legacy overtime supply addressing production meet our and balancing chain are chain supply the year. working increasing in demand, operations move last challenges while talent Precision Motion the the segment and from
improvements chain been, We we see The These team have our do. work and to we need supplier teams more are remain the which clearly our what on focused And needs, time can supply the innovation customer and not of in first customer meeting ratings, our knows to soon. progress. see challenges. foremost, and inefficiencies. we difficult manufacturing confident, the through will growth Our business the
business business, applications. saw laser-additive performance to our growth, We're Technology of the across execution Photonics with again, driven the which, we organic multiple mid- on material strong and units performance pleased continued organic of in to operations three segment. Two solid strong our high growth industrial the Cambridge experienced of the side business, manufacturing, processing and Turning single-digit revenue growth momentum and advanced micromachining. the to see delivered broad by
the packaged or win steering solutions, the solutions. our application-specific in winning proprietary Cambridge delivered customer customers with are to solid the our growth. business, most with business which fastest, We We're and also performance of due to Synrad pleased organic Technology very our accurate enabling highest-performing beam with technology
As we is a launch a normalizing it's product in facing year. Laser some growth before business major calls, last comps prior after tough spectacular and after indicated our Quantum
be and Quantum for this quarters. we Laser expect result, to few a in year-over-year next the revenue position declined quarter, in As the
As launch to is this performance which market lumpy. throughput quarterly sequencing, end DNA application any we be case, individual customer higher to related customer growth. discussed, in it unrelated can in dynamics is temporary In particular
terms better positioned Our and have more as and market. the to commercial not changed, matter position and couldn't growth capitalize excited be a prospects on long-term DNA of we sequencing fact, the of
year a for result the X% these the Photonics testament As of we executed dynamics. strength on Novanta of about book-to-bill X% that model business in temporary growth is despite Novanta's dynamics, a segment revenue with modestly a the our X organic diversified It declined last year-to-date. versus to of overall Laser by Quantum
than in XX% gross more robust New Photonics execution operations pleased finally, of year-to-date in was last product mix Photonics their the performance. and with and up as productivity, segment revenue year was evident and versus the margin we're
Turning The which lapped outcomes Invasive focused X% acquisition. such group third revenue Analysis. Invasive to errors, as quarter, & In and and for includes lab focused on clinical is our now technologies, Detection delivered Surgery, workflow and reducing patient applications, our improving includes we MIS sciences year-over-year vision growth two monitoring, in businesses, equipment. and and and vision Detection & endoscopy surgery segment, Minimally or is The NDS on WOM Surgery segment includes patient medical the WOM and life short, MIS as business group robotic Minimally applications. the our Analysis JADAK
discussed Our Minimally and we at Surgery have despite in Invasive tough business in WOM, as JADAK turned our to returned calls. prior comps business growth planned growth which solid
and the despite the change product noncore vision a second was that doubled expected WOM of by caused performed is versus New comps solid than regulatory we much half in in the last X.XX XXXX in with the the quarter. some product nonmedical than year, XXXX Despite better our across-the-board. exiting bookings more European WOM lines, and revenue book-to-bill year-to-date in tough segment fact
be in the quarter, we to mentioned. grew While expect the third next softer quarter to due the dynamics business
product organic products NDS and the such delivered as room and of consecutive We pleased acquisition products the product, management line. our image quarter, new video growth, by year-over-year driven are integrated quarter market. NDS displays, its seventh continued new addresses operating also In momentum the wireless XK with our which of
strong based Ludwigsstadt, us the quarter, its XXXX. announced center to track to quality, serve in This skill on consolidate production on Ludwigsstadt, into in and the customers be medical medical and enables remains within build the and plans equipment, one revenue allows better manufacturing existing we group which a growth medical for us to on efficiently our business to our effectively medical regulatory profit MIS our our capabilities -- and in net more In manufacturing substantially addition, scale. improved contributor the profitability Germany. to operations In and component global a regulatory
Jose, San the WOM Germany. will in manufacturing surgical NDS California, transfer result, in a Ludwigsstadt, As manufacturing facility to
complete XXXX. expect quarter by transfer third the We to the of
Finally, RFID & we're very Vision back pleased driven imaging Detection which scanning, Machine help our them we an wide to RFID the Vision by with growth In medical embedded the with now and OEM capability, barcode enhanced Along Analysis the systems. business, productivity. have improve the Analysis of & the and and JADAK's cameras quarter, existing expanded range we Vision. smart that solutions as of Machine a business including with offer execution technologies, Detection planned, can Machine to returned customers
pleased medical as that combined in markets, We're XXXX foundation wrapping sustainable is disciplined positions section, diversified solid approach very growth a in quarter. and to the So a and with growth. profitability providing our Novanta's my profitable across with the revenue outlook for leadership M&A, organic about we're industrial confident achieved we up
So over Robert our I on details more performance. that, to to call the with financial will Robert? turn provide
